Are you a Diabetic 2 patient who has been diagnosed with either thyroid cancer or pancreatic cancer after having been prescribed the medication Januvia as part of your treatment regimen? If so then you may be entitled to compensation from the medication’s manufacturer.
The attorneys at Danziger & De Llano have been representing victims of pharmaceutical company negligence for over two decades, and we are currently investigating reports that Januvia and other medications prescribed for the treatment of Diabetes 2 have been linked to potentially deadly side effects.
Januvia is one of a new class of drugs that encourages the creation of insulin within the pancreas. It also reduces the amount of glucose that the liver produces when the body signals that its levels are too high. Januvia can be taken orally, which has made it much more popular than other diabetes medications that need to be injected.
It is manufactured by drug giant Merck & Company, and has been approved for use by the Food and Drug Administration since the year 2006. It has become one of the most popular Diabetes 2 drugs on the market, with sales revenue topping $1 billion dollars in 2012 and growing to over $5 billion dollars the following year.
Link Between Januvia and Pancreatitis
But the drug’s popularity is tempered by recent concerns over its safety; the FDA released a statement in early 2013, warning of reports that indicated a link between Januvia and other, similar diabetes drugs with an increased risk of a variety of illnesses, including pancreatitis. Pancreatitis is an acute inflammation of the pancreas, and is a frequent precursor to pancreatic cancer, a particularly aggressive and deadly form of cancer.
If you have been diagnosed with pancreatic cancer or have suffered the pain of pancreatitis after having been prescribed Januvia, you may be eligible to file a Januvia lawsuit for compensation for your expenses and damages including lost wages, pain and suffering. The attorneys at Danziger & De Llano are highly qualified and can assess your eligibility and advise you as to your rights.
Entire Class of Medication Faces Scrutiny
Januvia is classified as an incretin mimetic – this means that it imitates incretin hormones that the body is supposed to create, but which are lacking in those that suffer from Diabetes 2. Other Diabetes 2 drugs, including Byetta, are facing similar scrutiny from the FDA as there have been reports that those who have taken the drugs have shown twice the risk of developing acute pancreatitis.
A study conducted by another medical group found evidence that those who were prescribed and used Januvia were more likely to develop cancer of the thyroid, and there have also been significant reports about the development of kidney disease among Januvia patients.
The results of some of the studies that were conducted are truly notable: the FDA reported that twenty-one percent of patients who had developed pancreatitis did so within one month of having begun to take Januvia, and approximately fifty percent of those cases were resolved after the patients stopped taking the medication.
As a result of this and similar results, the FDA has required Merck to add a warning label to Januvia prescriptions; though the company has added the warnings, they have done nothing to pull the product off of the market, despite the serious risks that it poses to patients who take it.
As a result, the lawyers at Danziger & De Llano are working on behalf of patients who have been diagnosed with thyroid cancer or pancreatitis or pancreatic cancer, gathering their medical records and preparing to file lawsuits on their behalf for compensation for their medical expenses and damages.
Let Danziger & De Llano Fight for You
The law firm of Danziger & De Llano has been representing clients who have been harmed by the negligence of big drug companies like Merck for decades; these companies are required to conduct extensive testing and investigation before releasing a medication onto the market for patients to take, yet far too frequently drugs are submitted for approval with inadequate testing and research.
As a result, patients and their families are made to suffer, and are required to pay traumatically high medical bills as well, often after having lost their ability to work due to the illness caused by the company’s negligence.